Literature DB >> 2927061

[Progressive multifocal leukoencephalopathy in Wegener's granulomatosis in relation to therapy with cyclosporin A].

J Ettinger1, W Feiden, G Hübner, M Schreiner.   

Abstract

A female patient with Wegener's granulomatosis developed severe bone marrow depression after two years treatment with cyclophosphamide. Corticosteroids alone could not sufficiently suppress disease activity, therefore additive therapy with Cyclosporin A was started. Four weeks later the patient developed a central nervous system disorder with affective disturbances and progressive somnolence. However, inspite of intensive diagnostic procedures, no definite diagnosis could be established. After another two months she died. Post-mortem-examination showed progressive multifocal leukoencephalopathy. An association between immunosuppressive therapy and reactivation of JC-Virus is suggested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2927061     DOI: 10.1007/BF01717330

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

Review 1.  Immune interventions in disease.

Authors:  J L Fahey; G Sarna; R P Gale; R Seeger
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

2.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  S A Houff; E O Major; D A Katz; C V Kufta; J L Sever; S Pittaluga; J R Roberts; J Gitt; N Saini; W Lux
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

3.  Immunological features of Wegener's granulomatosis.

Authors:  E J Shillitoe; T Lehner; M H Lessof; D F Harrison
Journal:  Lancet       Date:  1974-02-23       Impact factor: 79.321

4.  Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

Authors:  B L Padgett; D L Walker; G M ZuRhein; R J Eckroade; B H Dessel
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

5.  Papovavirus antigens in paraffin sections of PML brains.

Authors:  H Budka; K V Shah
Journal:  Prog Clin Biol Res       Date:  1983

6.  Progressive multifocal leukoencephalopathy: a burnt-out case.

Authors:  R W Price; S Nielsen; B Horten; M Rubino; B Padgett; D Walker
Journal:  Ann Neurol       Date:  1983-05       Impact factor: 10.422

7.  Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

8.  Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.

Authors:  E Willoughby; R W Price; B L Padgett; D L Walker; B Dupont
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

Review 9.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

10.  Virologic and serologic studies of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  Prog Clin Biol Res       Date:  1983
View more
  3 in total

Review 1.  An unusual case of multiple cranial nerve palsies in Wegener's granulomatosis.

Authors:  A D Daderian; S Chayasirisobhon
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

Review 2.  Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature.

Authors:  K Warnatz; H H Peter; M Schumacher; L Wiese; A Prasse; F Petschner; P Vaith; B Volk; S M Weiner
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

Review 3.  Progressive multifocal leukoencephalopathy during cyclosporine treatment. A case report.

Authors:  S Gentile; I Sacerdote; D Roccatello; M T Giordana
Journal:  Ital J Neurol Sci       Date:  1996-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.